Back to Network
3
Shared Docs
3
Same-Page
3 / 3
Mentions
Document Mentions (3 shared documents)
2 mentions1 same-page
Page ?Same page
iliation with or funding from Epstein," he said. "I unequivocally condemn his abhorrent actions involving minors." Lee McGuire, a spokesman for Mr. Lander, said he has had no relationship with Mr. Epstein. "Mr. Epstein appears to have made up lots of things," Mr. McGuire said, "and this seems to be amo
regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have benefited other companies — and may even have been
2 mentions1 same-page
Page ?Same page
iliation with or funding from Epstein," he said. "I unequivocally condemn his abhorrent actions involving minors." Lee McGuire, a spokesman for Mr. Lander, said he has had no relationship with Mr. Epstein. "Mr. Epstein appears to have made up lots of things," Mr. McGuire said, "and this seems to be amo
regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have benefited other companies — and may even have been
2 mentions1 same-page
Page ?Same page
iliation with or funding from Epstein," he said. "I unequivocally condemn his abhorrent actions involving minors." Lee McGuire, a spokesman for Mr. Lander, said he has had no relationship with Mr. Epstein. "Mr. Epstein appears to have made up lots of things," Mr. McGuire said, "and this seems to be amo
regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have benefited other companies — and may even have been
Sponsored
Mutual Connections (221)
Entities connected to both Lander and Investigational New Drug (IND
Jeffrey Epstein
PERSON45 w/ Lander·3 w/ Investigational
Martin Nowak
PERSON31 w/ Lander·3 w/ Investigational
Eric Trump
PERSON26 w/ Lander·3 w/ Investigational
Bill Clinton
PERSON9 w/ Lander·3 w/ Investigational
Julie K. Brown
PERSON9 w/ Lander·3 w/ Investigational
Department of Justice
ORGANIZATION8 w/ Lander·4 w/ Investigational
Donald Trump
PERSON8 w/ Lander·4 w/ Investigational
Bradley Edwards
PERSON8 w/ Lander·3 w/ Investigational
Sergey Brin
PERSON8 w/ Lander·3 w/ Investigational
CO
Collins
PERSON7 w/ Lander·3 w/ Investigational
Ghislaine Maxwell
PERSON7 w/ Lander·3 w/ Investigational
Alexander Acosta
PERSON7 w/ Lander·3 w/ Investigational
Prince Andrew
PERSON7 w/ Lander·3 w/ Investigational
Alan Dershowitz
PERSON7 w/ Lander·3 w/ Investigational
Virginia Giuffre
PERSON6 w/ Lander·4 w/ Investigational
Santa Fe
LOCATION7 w/ Lander·3 w/ Investigational
Steven Pinker
PERSON6 w/ Lander·3 w/ Investigational
Paul Cassell
PERSON6 w/ Lander·3 w/ Investigational
Osama bin Laden
PERSON6 w/ Lander·3 w/ Investigational
Phoenix
LOCATION6 w/ Lander·3 w/ Investigational